aod9604 human clinical trials weight loss results The effects of 14 day infusion of saline (control), (250 The Journey of AOD-9604: From

Individuals considering extended protocols should understand this temporal limitation in the safety database

AOD 9604 is not FDA-approved for fat loss or any other indication

AOD-9604 (also catalogued as hGH Fragment 176191 or Tyr-hGH 177191) is a 16-amino-acid synthetic peptide derived from the C-terminal region of human growth hormone

Key finding: AOD 9604 showed superior lipolytic activity (EC50 45 nM) versus native GH (EC50 380 nM) with insulin-independent mechanism

For combination protocols where maximizing AOD 9604 effectiveness matters, injectable is strongly preferred

This approach maintains more consistent beta-3 receptor stimulation throughout the 24-hour period